Vertex Pharmaceuticals (NASDAQ: VRTX)
Vertex Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Vertex Pharmaceuticals Company Info
Vertex is in the business of discovering, developing, and commercializing small-molecule drugs for the treatment of serious genetic diseases including cystic fibrosis.
News & Analysis
Vertex Pharmaceuticals Tops Q3 Estimates
The cystic fibrosis treatment leader's revenue and earnings exceeded expectations.
The Best CRISPR Companies to Invest In
These CRISPR stocks could be big winners for patient investors.
Top Biotech ETFs to Buy Now
Here are the five best biotech ETFs to invest in right now.
The Smartest Growth Stock to Buy With $500 Right Now
This stock might not be available for under $500 for long.
Vertex Pharmaceuticals Just Found Its Newest Blockbuster Drug. A $41 Billion Market Awaits
Its latest report of clinical data suggests it has a winner on its hands.
Investing in Life Sciences Stocks
Got $1,000? 2 Magnificent Growth Stocks to Buy and Hold Forever
These profitable companies are facing long-term growth runways.
2 Biotech Stocks to Buy Hand Over Fist in October
These longtime leading biotech stocks still have plenty of upside ahead.
Valuation
Podcast Episodes
Alleged Industrial Espionage Makes an Interesting Story
We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment.
3 Biotech Companies Analyzed
We examine three biotech companies' past performances and future outlooks.
Is Amarin's Fish Oil Pill on Track to Become a Blockbuster?
Plus, how gene-editing company CRISPR Therapeutics just took a big step forward.
Earnings Transcripts
Vertex Pharmaceuticals (VRTX) Q3 2024 Earnings Call Transcript
VRTX earnings call for the period ending September 30, 2024.
Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript
VRTX earnings call for the period ending June 30, 2024.
Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript
VRTX earnings call for the period ending March 31, 2024.
Vertex Pharmaceuticals (VRTX) Q4 2023 Earnings Call Transcript
VRTX earnings call for the period ending December 31, 2023.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.